Condition: Duchenne Muscular Dystrophy
Intervention: Drug: AVI-4658 (Eteplirsen)
Sponsor: AVI BioPharma, Inc.
Enrolling by invitation - verified July 2011
By ClinicalTrials.gov 
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.